EPISODE · Sep 22, 2025 · 17 MIN
Treatment Algorithm of Neuroendocrine Tumors (NET) in 2025 - Dr. Thor Halfdanarson
from Oncology Brothers: Practice-Changing Cancer Discussions · host Oncology Brothers
Welcome to the Oncology Brothers podcast! In this episode, we dive deep into the world of neuroendocrine tumors (NETs) with renowned expert Dr. Thor Halfdanarson from the Mayo Clinic.Join us as we explore:• The critical factors in diagnosing NETs, including origin, grade, histological features, and Ki-67.• The importance of differentiating between functional and non-functional tumors and how this impacts treatment decisions.• Dr. Halfdanarson's treatment paradigm, including the use of somatostatin analogs, radioligand therapy, and other targeted treatments.• Monitoring strategies for patients, including the role of imaging and tumor markers like 5-HIAA and chromogranin.• Insights into the evolving role of immunotherapy and next-generation sequencing in managing high-grade neuroendocrine carcinomas.Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode is packed with valuable information and practical insights.Follow us on social media:• X/Twitter: https://twitter.com/oncbrothers• Instagram: https://www.instagram.com/oncbrothers• Website: https://oncbrothers.com/Don't forget to subscribe for more discussions on cutting-edge cancer treatments and expert opinions in the field of oncology!
What this episode covers
Welcome to the Oncology Brothers podcast! In this episode, we dive deep into the world of neuroendocrine tumors (NETs) with renowned expert Dr. Thor Halfdanarson from the Mayo Clinic.Join us as we explore:• The critical factors in diagnosing NETs, including origin, grade, histological features, and Ki-67.• The importance of differentiating between functional and non-functional tumors and how this impacts treatment decisions.• Dr. Halfdanarson's treatment paradigm, including the use of somatostatin analogs, radioligand therapy, and other targeted treatments.• Monitoring strategies for patients, including the role of imaging and tumor markers like 5-HIAA and chromogranin.• Insights into the evolving role of immunotherapy and next-generation sequencing in managing high-grade neuroendocrine carcinomas.Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode is packed with valuable information and practical insights.Follow us on social media:• X/Twitter: https://twitter.com/oncbrothers• Instagram: https://www.instagram.com/oncbrothers• Website: https://oncbrothers.com/Don't forget to subscribe for more discussions on cutting-edge cancer treatments and expert opinions in the field of oncology!
NOW PLAYING
Treatment Algorithm of Neuroendocrine Tumors (NET) in 2025 - Dr. Thor Halfdanarson
No transcript for this episode yet
Similar Episodes
Mar 31, 2026 ·54m
Mar 27, 2026 ·14m
Mar 24, 2026 ·42m
Mar 20, 2026 ·42m
Mar 17, 2026 ·41m
Mar 13, 2026 ·44m